ArticleEuropean geriatric medicine2026
Are we making progress in the diagnosis and management of sarcopenia? Results from a UK-wide survey.
Article in European geriatric medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
purposeTo describe current practice in diagnosis and management of sarcopenia in older people in the United Kingdom (UK).
methodsHealthcare professionals from UK organisations were invited to complete an online survey about sarcopenia diagnosis and management.
resultsOne hundred and one responses were analysed. Respondents represented a range of professional groups across 62 organisations from secondary care, primary care, community providers and private practitioners. Sarcopenia was identified in only 32/62 (52%) organisations. Within these organisations, 17/32 (53%) did not use a recognised algorithm for diagnosis, although 31/32 (97%) of organisations assessed muscle strength. Twenty-nine (91%) organisations reported offering interventions to people diagnosed with sarcopenia, but resistance training was offered by only 19 (59%).
conclusionThis survey has shown that just over 50% of respondent organisations in the UK are identifying sarcopenia in older people as part of clinical practice, highlighting the need for ongoing work to achieve further improvement.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.